Etaracizumab (Anti-Integrin aVb3 (ITGAV & ITGB3))
Etaracizumab (Anti-Integrin aVb3 (ITGAV & ITGB3)) (A2991-GRP)
Products
Description
Etaracizumab (Anti-Integrin aVb3 (ITGAV & ITGB3)) is an IgG1 monoclonal antibody targeting αvβ3 integrin. It inhibits angiogenesis and melanoma tumor growth and can be used to research anticancer. MW :144.18 KD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A2991 |
| Target | Integrin |